The list price of a vial of rapid-acting NovoLog, one of the most widely used insulin products, will fall to $72, from $289. The new price was still about twice what it was when NovoLog was ...

Novo Nordisk will no longer be manufacturing Levemir ® (insulin detemir [rDNA origin] injection), according to a discontinuation notice posted by the Company. Levemir is a long-acting human ...

Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternatives.

Novo Nordisk has developed a new version of the insulin analogue, called Fiasp, which added another DKK 1.6 billion to the fast-acting insulin pot last year and has patent protection to 2030.

Three Senate Democrats are demanding answers from Novo Nordisk over its decision to discontinue Levemir, which is FDA-approved for pregnancy.

Novo Nordisk plans to slash the U.S. list prices for several of its insulin drugs by as much as 75%, the company said on Tuesday. The move follows Eli Lilly's announcement earlier this month that ...

Novo Nordisk said Tuesday that its popular fast-acting insulins NovoLog and NovoLog Mix 70/30 will cost $72.34 for a single vial and $139.71 for a pen, a 75% decrease in price.

Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens ...

Novo Nordisk CEO explains decision to discontinue the long-acting insulin Levemir. He blamed pharmacy managers and health insurers.

The prices for Novo Nordisk products Novolin and Levemir, longer-acting forms of insulin, will be cut down by 65 percent, dropping to $107.85 and $48.20 in their vial forms, respectively.

Merilog, made by Sanofi-Aventis, is a rapid-acting insulin biosimilar (similar to Novo Nordisk’s Novolog) that helps control blood sugar spikes when taken five to 10 minutes before a meal.

Kennewick/Pixabay Novo Nordisk is dropping the price of its fast-acting insulins, NovoLog and NovoLog Mix 70/30, 75% to $72.34 per vial and $139.71 per pen.